These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1348 related items for PubMed ID: 35120753

  • 1. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
    Schröder CM, Broquère MA, Claustrat B, Delorme R, Franco P, Lecendreux M, Tordjman S.
    Encephale; 2022 Jun; 48(3):294-303. PubMed ID: 35120753
    [Abstract] [Full Text] [Related]

  • 2. [Sleep disorders in patients with a neurocognitive disorder].
    Moderie C, Carrier J, Dang-Vu TT.
    Encephale; 2022 Jun; 48(3):325-334. PubMed ID: 34916075
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A, Schroder CM, Malow BA, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P.
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL.
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology and management of insomnia in children with autistic spectrum disorders.
    Miano S, Ferri R.
    Paediatr Drugs; 2010 Apr 01; 12(2):75-84. PubMed ID: 20218744
    [Abstract] [Full Text] [Related]

  • 6. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
    Appleton RE, Jones AP, Gamble C, Williamson PR, Wiggs L, Montgomery P, Sutcliffe A, Barker C, Gringras P.
    Health Technol Assess; 2012 Apr 01; 16(40):i-239. PubMed ID: 23098680
    [Abstract] [Full Text] [Related]

  • 7. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 8. Insomnia in children affected by autism spectrum disorder: The role of melatonin in treatment.
    Bruni O, Biggio G, Malorgio E, Nobili L.
    Sleep Med; 2024 Jul 16; 119():511-517. PubMed ID: 38805858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sleep disturbances in subjects with autism spectrum disorder: A parental perspective.
    Bernardi K, Prono F, Bruni G, Panerai S, Ferri R, Bruni O.
    Sleep Med; 2023 Oct 16; 110():220-224. PubMed ID: 37643569
    [Abstract] [Full Text] [Related]

  • 11. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan 16; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL, Magee M, Murray JM, Gordon CJ, Lovato N, Kennaway DJ, Gwini SM, Bartlett DJ, Lockley SW, Lack LC, Grunstein RR, Rajaratnam SMW, Delayed Sleep on Melatonin (DelSoM) Study Group.
    PLoS Med; 2018 Jun 16; 15(6):e1002587. PubMed ID: 29912983
    [Abstract] [Full Text] [Related]

  • 13. The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review.
    Rana M, Kothare S, DeBassio W.
    J Can Acad Child Adolesc Psychiatry; 2021 Feb 16; 30(1):25-35. PubMed ID: 33552170
    [Abstract] [Full Text] [Related]

  • 14. Autism Spectrum Disorder and Sleep.
    Johnson KP, Zarrinnegar P.
    Child Adolesc Psychiatr Clin N Am; 2021 Jan 16; 30(1):195-208. PubMed ID: 33223062
    [Abstract] [Full Text] [Related]

  • 15. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder.
    Zisapel N.
    Expert Rev Clin Pharmacol; 2022 Feb 16; 15(2):175-185. PubMed ID: 35285365
    [Abstract] [Full Text] [Related]

  • 16. [Sleep problems and the association with the levels of 6-sulfatoxymelatonin in children with autism spectrum disorder].
    Han PP, Zou MY, Yang XL, Liu XC, Liang S, Sun CH, Xia W, Wu LJ.
    Zhonghua Er Ke Za Zhi; 2017 Dec 02; 55(12):911-915. PubMed ID: 29262470
    [Abstract] [Full Text] [Related]

  • 17. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial.
    Gringras P, Gamble C, Jones AP, Wiggs L, Williamson PR, Sutcliffe A, Montgomery P, Whitehouse WP, Choonara I, Allport T, Edmond A, Appleton R, MENDS Study Group.
    BMJ; 2012 Nov 05; 345():e6664. PubMed ID: 23129488
    [Abstract] [Full Text] [Related]

  • 18. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC, Mungiu OC.
    Rev Med Chir Soc Med Nat Iasi; 2012 Nov 05; 116(3):862-6. PubMed ID: 23272543
    [Abstract] [Full Text] [Related]

  • 19. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
    Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D.
    J Sleep Res; 2012 Dec 05; 21(6):700-9. PubMed ID: 22616853
    [Abstract] [Full Text] [Related]

  • 20. Autism Spectrum Disorder and Sleep.
    Johnson KP, Zarrinnegar P.
    Psychiatr Clin North Am; 2024 Mar 05; 47(1):199-212. PubMed ID: 38302207
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 68.